Market Cap 166.08M
Revenue (ttm) 0.00
Net Income (ttm) -41.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 4,666,300
Avg Vol 5,430,908
Day's Range N/A - N/A
Shares Out 85.17M
Stochastic %K 32%
Beta 0.41
Analysts Strong Sell
Price Target $6.60

Company Profile

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collabora...

Industry: Biotechnology
Sector: Healthcare
Phone: 514 336 0444
Address:
1111 Dr. Frederik-Philips Boulevard, Suite 420, Montreal, Canada
deweyeggbert
deweyeggbert Dec. 25 at 4:57 AM
$MIST The big dogs have secured their positions. Watch this one go nuts over the next few weeks. I estimate $5 by Feb.
0 · Reply
Bio_Invest101
Bio_Invest101 Dec. 24 at 10:49 PM
$MIST Hope news soon traps the record SI
0 · Reply
Salvo1968
Salvo1968 Dec. 24 at 10:47 PM
0 · Reply
RunnerSignals
RunnerSignals Dec. 24 at 9:26 PM
Market Warriors $PALI $MIST $SATL $CRDF $BW shook off the dip and finished like champs. Intraday reversals everywhere worth a closer look
0 · Reply
PortfolioMgmt23
PortfolioMgmt23 Dec. 24 at 8:16 PM
$MIST Merry Christmas to all my fellow longs! The climb upward begins with each day ahead.
0 · Reply
ImmxBeliever
ImmxBeliever Dec. 24 at 7:23 PM
$CVM $MIST This guy is a real moron. No. Really Offering coming any day now. Furthermore, Phase III trial failed all primary and secondary endpoints. Read this Article from four years ago when the trial data was published They still haven’t been able to get this thing in front of the FDA https://www.fiercebiotech.com/biotech/cel-sci-cancer-phase-3-misses-primary-endpoint-sinking-stock Cheers
0 · Reply
Idgaf1972
Idgaf1972 Dec. 24 at 7:14 PM
$MIST Nice surprise today. Merry Christmas
0 · Reply
Playfire
Playfire Dec. 24 at 7:02 PM
$MIST Good day today, the stupid monkey who shorted this stock is on vacation, Merry Christmas everyone🤗
0 · Reply
jacksparo
jacksparo Dec. 24 at 6:51 PM
$MIST Well not a bad close .. But I know it needs more time 📈✅!
0 · Reply
XL250
XL250 Dec. 24 at 6:24 PM
$MIST 2026 will be a big year! $CVM Has some big news coming it will go big or go away I'm in big on both of these now. Dont take my advice i am not a pro.
1 · Reply
Latest News on MIST
Milestone® Pharmaceuticals to Present at Upcoming Conferences

Aug 19, 2025, 8:00 AM EDT - 4 months ago

Milestone® Pharmaceuticals to Present at Upcoming Conferences


Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge

Jul 11, 2025, 2:37 PM EDT - 5 months ago

Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge


Milestone Pharmaceuticals Announces Proposed Public Offering

Jul 11, 2025, 6:01 AM EDT - 5 months ago

Milestone Pharmaceuticals Announces Proposed Public Offering


FDA Issues Complete Response Letter for Etripamil for PSVT

Mar 28, 2025, 7:00 AM EDT - 9 months ago

FDA Issues Complete Response Letter for Etripamil for PSVT


deweyeggbert
deweyeggbert Dec. 25 at 4:57 AM
$MIST The big dogs have secured their positions. Watch this one go nuts over the next few weeks. I estimate $5 by Feb.
0 · Reply
Bio_Invest101
Bio_Invest101 Dec. 24 at 10:49 PM
$MIST Hope news soon traps the record SI
0 · Reply
Salvo1968
Salvo1968 Dec. 24 at 10:47 PM
0 · Reply
RunnerSignals
RunnerSignals Dec. 24 at 9:26 PM
Market Warriors $PALI $MIST $SATL $CRDF $BW shook off the dip and finished like champs. Intraday reversals everywhere worth a closer look
0 · Reply
PortfolioMgmt23
PortfolioMgmt23 Dec. 24 at 8:16 PM
$MIST Merry Christmas to all my fellow longs! The climb upward begins with each day ahead.
0 · Reply
ImmxBeliever
ImmxBeliever Dec. 24 at 7:23 PM
$CVM $MIST This guy is a real moron. No. Really Offering coming any day now. Furthermore, Phase III trial failed all primary and secondary endpoints. Read this Article from four years ago when the trial data was published They still haven’t been able to get this thing in front of the FDA https://www.fiercebiotech.com/biotech/cel-sci-cancer-phase-3-misses-primary-endpoint-sinking-stock Cheers
0 · Reply
Idgaf1972
Idgaf1972 Dec. 24 at 7:14 PM
$MIST Nice surprise today. Merry Christmas
0 · Reply
Playfire
Playfire Dec. 24 at 7:02 PM
$MIST Good day today, the stupid monkey who shorted this stock is on vacation, Merry Christmas everyone🤗
0 · Reply
jacksparo
jacksparo Dec. 24 at 6:51 PM
$MIST Well not a bad close .. But I know it needs more time 📈✅!
0 · Reply
XL250
XL250 Dec. 24 at 6:24 PM
$MIST 2026 will be a big year! $CVM Has some big news coming it will go big or go away I'm in big on both of these now. Dont take my advice i am not a pro.
1 · Reply
XL250
XL250 Dec. 24 at 6:17 PM
$MIST Glad I loaded up yesterday! Merry Christmas!
0 · Reply
johnnydankworth
johnnydankworth Dec. 24 at 6:09 PM
$MIST So just thinking a bit. If several of the largest institutional holders agree would they not have a controlling voice on a vote regardless of what the board thinks should an offer appear?
0 · Reply
CoinRaider
CoinRaider Dec. 24 at 6:07 PM
$MIST Keep it up clown.
1 · Reply
BioRich
BioRich Dec. 24 at 5:34 PM
$MIST I still maintain that $MIST is going to pull a miracle and show they have sales and/or scripts written by the end of the year. WS will go bonkers if they do. Fingers crossed. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers!
4 · Reply
BioRich
BioRich Dec. 24 at 5:30 PM
$MIST Great post by @Drashkawisha. Nice right-sizing of $MIST current status. I haven't sold a single share, and never considered it. Market response, while painful at the time, aligns with Institutions and MMs loading up before commercialization numbers coming in. Why they play it this way? Retail loves approvals, which don't usually equate to instant (or near instant) commercialization. $MIST is different. They had their Sales Team ready to go to get folks on board and get scripts written almost immediately. This is not normal. I believe WS's bet is that commerciazation will be extremely successful and we see our jump there when a lot of retail holding for the binary event has exited. Time will tell, but my confidence remains strong and unwavered in $MIST. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers! $XBI
1 · Reply
10sense
10sense Dec. 24 at 5:16 PM
0 · Reply
Bennyman369
Bennyman369 Dec. 24 at 5:13 PM
$MIST 🤣🤣🤣👇🤡🤡🤡
1 · Reply
SouthHaus
SouthHaus Dec. 24 at 5:11 PM
$MIST Merry Christmas y’all! May the season for MISTletoe extend far beyond the traditional Twelve Days!
0 · Reply
jow18
jow18 Dec. 24 at 5:04 PM
$MIST Merry Christmas MIST fam
0 · Reply
Drashkawisha
Drashkawisha Dec. 24 at 4:56 PM
$MIST The Setup: Panic sellers are blind. FDA approval triggered a $75M non-dilutive payment from RTW. The Math: Market Cap is ~$160M. Pro-forma cash is ~$120M. You are buying the actual drug pipeline for peanuts. Next Up: Launch updates & Phase 3 AFib data. The floor is in.
4 · Reply
BioRich
BioRich Dec. 24 at 4:47 PM
$OMER Congrats on the approval and SP jump. This is how I thought $MIST was going to go after their approval, but we saw a slight pull back. $MIST will get there but the $OMER type jump is always preferred. Congrats to the $OMER longs!
0 · Reply
gplns
gplns Dec. 24 at 4:00 PM
$MIST I’m buying FBIO now after having winning streak in AGIO & OMER. As I said earlier FDA is in approval spree. Do not miss that opportunity before they change their mind.
1 · Reply